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OA group. Hyaluronan scaffold displayed only a minor role in favoring
the wound-healing processes in the cartilage, synovial membrane and
menisci. There were instead a general beneﬁcial effect on these tissues,
when this scaffold was implanted with BMC and/or MSC. Macroscopic,
histological and immunohistochemical assessments clearly showed in
detail in BMC group an enhancement of cartilage repair in terms of a
down-regulation of some ﬁbrous, catabolic, hypertrophic and inﬂam-
matory markers particularly in medial femoral condyle respect OA
group (P<0.05). Moreover, the use of BMC determined an improvement
of various histological aspects in synovial membrane and menisci
reducing the ﬁbrous and inﬂammatory states respect OA group. MSC
group displayed a positive contribution particularly on medial femoral
condyle and low effect in tibial plateau due to the biomechanics of the
articular joint in sheep.
Conclusions: The sheep was chosen for this work because of its sim-
ilarities with humans, which render it an useful model. The ﬁndings
obtained in this study would support the use of BMC in clinical practice
for OAmanagement, as useful therapeutic tool, leading to a reduction of
the degenerative and inﬂammatory processes in cartilage, synovial
membrane and menisci during OA setting. Moreover, the clinical
application of BMC in OA management is attractive because it would
allow a one- step procedure, avoiding all the complications related to in
vitro cell manipulation, thus complying with US Food and Drug Asso-
ciation (FDA) restrictions.
24
ALTERATIONS OF THE SUBCHONDRAL BONE INDUCED BY PTH [1-34]
PROVOKE EARLY OSTEOARTHRITIS IN VIVO
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H. Madry y. yCtr. of Experimental Orthopaedics, Saarland Univ., Homburg/
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Informatics, Saarland Univ., Homburg/Saar, Germany; x Inst. of Clinical
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Purpose: Systemic application of the 1-34 amino acid segment of the
parathyroid hormone (PTH [1-34]) stimulates bone formation, enhan-
ces diaphyseal fracture healing, and is approved for the clinical treat-
ment of postmenopausal osteoporosis. However, the effect of PTH [1-
34] on the subchondral bone is poorly understood. Here, we tested the
hypothesis that subcutaneous application of PTH [1-34] over 6 weeks
induces changes in the microarchitecture of the subchondral bone that
reciprocally affect the integrity of the articular cartilage within a naïve
osteochondral unit in vivo.
Methods: Daily subcutaneous injections of 10 mg PTH [1-34] per kg
body weight were given to the treatment group (n ¼ 4 adult female
Chinchilla bastard rabbits) for 6 weeks, controls received saline. The
animals were allowed full weight bearing and were fed a standard diet.
Blood samples were continuously collected to monitor renal function.
After sacriﬁce, the subchondral bone plate and subarticular spongiosa of
the femoral heads (n ¼ 16) were separately assessed by micro-com-
puted tomography. Osteoarthritic changes of the articular cartilage
were evaluated by macroscopic assessment and histological grading of
safranin orange/fast green stained sections, by polarized light micro-
scopy, and by computerized assessment of the mean immunostaining
intensities for type-I, type-II, and type-X collagen (Acris, Hiddenhausen,
Germany). Absolute and relative extents of hyaline and calciﬁed artic-
ular cartilage layers were determined histomorphometrically in a
standardized fashion on Goldner’s trichrome stained sections. The
effect of PTH [1-34] on apoptosis and PTH receptor (PTH1R) expression
of osteocytes and chondrocytes was determined by immunostaining,
applying a polyclonal caspase-3 (Cell Signaling Technology, Frankfurt,
Germany) and a monoclonal mouse PTH1R antibody (Abcam, Cam-
bridge, UK), respectively. Statistical comparison was conducted using a
linear model with generalized estimating equations. The Pearson cor-
relation coefﬁcient was applied to determine the strength of association
between PTH-induced key changes in subchondral bone and articular
cartilage. Data are given as mean  standard deviation. Two-tailed
values of p < 0.05 were considered signiﬁcant.
Results: PTH [1-34] enhanced bone volume (BV/TV; 45.58 3.69 versus
40.12  3.35%; p ¼ 0.010), mineral density (BMD; 1,062.48  104.16
versus 931.59  60.94 mg calcium hydroxyapatite/cm3; p ¼ 0.017), and
trabecular thickness (Tb.Th; 0.14  0.01 versus 0.13  0.01 mm; p ¼0.042) within the subarticular spongiosa, without affecting the sub-
chondral bone plate. Besides, PTH [1-34] signiﬁcantly increased the
thickness of the calciﬁed cartilage layer (285.32  46.17 versus 163.45
31.30 mm; p¼ 0.001). Moreover, PTH [1-34] also increased degeneration
of the articular cartilage (4.28 1.47 versus 1.97  0.46 overall score
points; p ¼ 0.040), reﬂected by cartilage surface irregularities (1.11 
0.96 versus 0.25  0.59; p < 0.001) and reduced matrix staining (2.75 
1.65 versus 1.68  0.55; p ¼ 0.029). Importantly, statistical analysis
revealed that such early osteoarthritic changes of the articular cartilage
correlate with (r ¼ 0.56) and are ascribed to the increased thickness of
the calciﬁed cartilage layer (p ¼ 0.026) and the enhanced mineral
density of the subarticular spongiosa (p ¼ 0.001). Systemic admin-
istration of PTH [1-34] neither affected the rate of apoptotic osteocytes
and chondrocytes within the osteochondral unit nor induced renal
failure, as serum levels of creatinine, phosphate, and urea nitrogen
remained constant over the observation period and were similar
between treatment and control group (p > 0.05 for all time points). The
macroscopic aspect of the articular cartilage, type-I, type-II, type-X
collagen content and distribution, and PTH1R expression remained
unaffected (all p > 0.05).
Conclusions: These ﬁndings identify a mechanism by which systemic
PTH [1-34] may provoke early osteoarthritis of the hyaline articular
cartilage by inducing microarchitectural modiﬁcations of the sub-
articular spongiosa and broadening of the calciﬁed cartilage layer.
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SENSITIZATION AND PAIN OVER TWO YEARS: THE MULTICENTER
OSTEOARTHRITIS (MOST) STUDY
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Purpose: Peripheral and central sensitization is associated with knee
pain severity in knee osteoarthritis (OA). Whether sensitization occurs
prior to or only concurrently with development of OA pain is not known
as prior studies have only been cross-sectional. Such insights would
have implications for understanding whether sensitization may be an
inherent trait vs. an induced state. We report here the ﬁrst longitudinal
evaluation of the effect of sensitization and its change over two years to
the incidence of knee pain and clinically meaningful change in pain
severity.
Methods: The Multicenter Osteoarthritis (MOST) Study is a NIH-funded
longitudinal cohort of persons with or at risk of knee OA. Subjects had
x-rays and WOMAC pain severity obtained at each study visit, and a
standardized somatosensory evaluation of mechanical temporal sum-
mation and pressure pain thresholds (PPT) at the wrist and patella at
60- and 84-months. Temporal summation was deﬁned by increased
pain during repeated mechanical stimulation (1 Hz x 30-sec) with a 60g
monoﬁlament. PPT was assessed with an algometer (1cm2 tip, 0.5 Kg/
sec) as the point at which the subject felt the pressure change to slight
pain. The average of 3 PPT trials was categorized into sex-speciﬁc ter-
tiles. Lower PPT indicates more sensitivity. Incident consistent frequent
knee pain (CFKP, pain on most days of the past 30 days on both a tel-
ephone screen and clinic visit) at the 84-month visit was determined
from among knees that did not have CFKP at the 60-month visit. Inci-
dent symptomatic knee OA (SxOA) at the 84-mo visit was deﬁned as
radiographic knee OA (ROA, KL grade 2) plus CFKP, assessed among
knees free of pain at the 60-mo visit with or without ROA. We used the
minimal clinically important difference (MCID) in WOMAC pain to
examine sensitization effects on clinically meaningful changes in pain
severity. We examined the relation of the baseline and 2-year changes
in somatosensory tests to each of these pain outcomes using logistic
regression with GEE. All analyses were adjusted for potential con-
founders (see Table for list).
Results: A total of 2308 subjects met eligibility criteria for these anal-
yses (mean age 67.6, mean BMI 30.9, 61% female). Neither temporal
summation nor PPT were associated with incident CFKP or incident
SxOA (ORs 0.7-1.2, all p>0.05). Baseline temporal summation at the
wrist was associated with a trend towards increased risk of MCID in
WOMAC pain worsening at follow-up, but baseline PPT was not asso-
ciated (Table). However, a decrease in PPT (:sensitivity) over 2 years
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(Table).
Conclusions: While measures of sensitization are associated with knee
OA pain presence and severity cross-sectionally, they were not related
longitudinally to development of new pain symptoms over 2 years;
however, this is difﬁcult to properly assess without carefully evaluating
descending inhibitory effects concurrently. Baseline presence of tem-
poral summation at the wrist may be associated with pain worsening,
suggesting a potential trait-like phenomenon for this ﬁnding, while
baseline PPT was not. However, decreases in PPT (i.e., increase in
mechanical hyperalgesia) over 2 years were associated with clinically
meaningful increased pain severity, suggesting a state-like phenom-
enon. Enhanced pain sensitivity coinciding with new/increased knee
pain may be mediated by sensitization or an imbalance between
descending facilitation and inhibition. These results suggest that such
changes may not necessarily precede development of knee pain, but
may inﬂuence the experience of pain and its severity once pain has been
established.Table
Relation of Temporal Summation and PPT to MCID in WOMAC pain worsening
MCID WOMAC pain
worsening Adjusted
OR (95% CI)
Temporal Summation:
Temporal summation present at baseline
Wrist 1.19 (0.98-1.44), p¼0.07
Patella 1.09 (0.91-1.31), p¼0.3
Incident temporal summation at follow-up
Wrist 1.16 (0.89-1.53), p¼0.3
Patella 1.23 (0.93-1.62), p¼0.1
Pressure Pain Threshold (PPT):
Baseline PPT tertiles
[lowest and middle vs. highest (REF)]
Wrist 0.99 (0.80-1.22), 0.88
(0.71-1.10), p¼0.4 for
trend
Patella 1.06 (0.85-1.32), 1.00
(0.81-1.24), p¼0.8 for
trend
Change in PPT baseline to follow-up Per unit decrease in PPT:
Wrist 1.08 (1.01-1.15), p¼0.03
Patella 1.12 (1.07-1.19), p<0.0001
Wrist: person-based analyses; Patella: knee-based analyses
Adjusted for potential confounders: age, sex, BMI, race, knee injury, KL, depressive
symptoms, catastrophizing
MCID¼minimally clinically important difference26
VIGOROUS BUT NOT MODERATE PHYSICAL ACTIVITY IS RELATED TO
STRUCTURAL PROGRESSION OF KNEE OSTEOARTHRITIS OVER ONE
YEAR
D. Kumar, L. Nardo, N.E. Calixto, J. Singh, T.M. Link, S. Majumdar. Univ. of
California San Francisco, San Francisco, CA, USA
Purpose: The purpose of this study was to investigate the association of
self-reported physical activity with structural progression of knee
osteoarthritis (OA) over a period of one year.
Methods: Baseline and one year data of 99 from 160 subjects have been
analyzed from an ongoing longitudinal Cartilage Loading and Unloading
(CLOC) knee OA study. All subjects underwent 3.0 Tesla MR imaging of
the knee using a 3-D sagittal high resolution T2-weighted fat-saturated
isotropic (3D FSE Cube) sequence at baseline and one year later. Pro-
spective registration was used to ensure similar ﬁeld of view between
timepoints. Cartilage defects were graded on a modiﬁed Whole Organ
Magnetic Resonance Score (mWORMS) for knee OA for both timepoints.
Kellgren-Lawrence score andmechanical axis were obtained at baseline
using a weight-bearing postero-anterior ﬁxed ﬂexion radiograph and
long limb radiograph respectively. Self-reported pain and symptoms
were assessed using the Knee Osteoarthritis and injury Outcome Survey
(KOOS); and physical activity was assessed using the International
Physical Activity Questionnaires (IPAQ) short-form at both timepoints.
IPAQ scores were calculated in metabolic equivalent-minutes/week
(MET-min/week). Progression was deﬁned as an increase in the carti-
lage defect score in any knee compartment at one year compared tobaseline. Subjects were stratiﬁed into progressors and non-progressors.
Oneway ANOVA was used to compare baseline characteristics between
the groups. A stepwise logistic regression model with age, BMI, gender,
pain, KL, and cartilage mWORMS in the 1st block, and IPAQ scores in the
2nd block, was run to estimate odds ratios (OR) of knee OA progression
with different risk factors. Mixed ANOVA was used to assess group by
time interactions in the change in KOOS and IPAQ scores over time in
the 2 groups. Finally, correlations between change in symptoms and
physical activity levels were evaluated in the two groups.
Results: Of the 99 subjects, 35 had an increase in the cartilage
mWORMS score at one year compared to baseline. At baseline the
progressors and non-progressors did not have signiﬁcant differences in
age, BMI, mechanical axis, self-reported pain and symptoms, and the
distributions of gender, KL, and mWORMS. The progressors had
engaged in greater MET-minutes/week of vigorous (D 997  483 MET-
min/week, P ¼ 0.042) but not moderate (D 235 276 MET-min/week, P
¼ 0.396) or walking (D 401  277 MET-min/week, P ¼ 0.151) physical
activity at baseline compared to non-progressors. Logistic regression
showed the physical activity scores made a signiﬁcant contribution
(step c2 ¼ 8.0, P ¼ 0.046) to predicting the classiﬁcation of subjects as
progressors vs. non-progressors, after accounting for age, BMI, gender,
KL, pain, and mWORMS. Engaging in vigorous physical activity was
associated with an OR of 1.35 (95% Conﬁdence Intervals ¼ 1.03 and 1.77,
P ¼ 0.032) of being classiﬁed as a progressor. The OR were not sig-
niﬁcant for moderate physical activity (OR ¼ 0.80, P ¼ 0.382) and was
close to signiﬁcance for walking activity (OR ¼ 1.43, P ¼ 0.075). We
observed a signiﬁcant group by time interaction (P¼ 0.007) for vigorous
physical activity with the progressors showing a decrease over time and
non-progressors showing an increase. Finally, in the progressors, there
was a signiﬁcant correlation between a decrease in vigorous physical
activity and a decrease in pain (R2¼ 0.13) and symptoms (R2¼ 0.16). No
such association was observed in the non-progressors.
Conclusions: Engaging in vigorous, but not moderate, physical activity
was found to be associated with 1.35 times greater risk of worsening
cartilage lesions. Furthermore, an association was observed between
decreasing vigorous physical activity and improvements in pain and
symptoms. These ﬁndings provide evidence that in moderate rather
vigorous levels of physical activity may be more appropriate for pre-
venting progression of knee OA. This work has been funded by NIH-
NIAMS RO1 AR046905.
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Purpose: Recent literature has suggested that low and high levels of
physical activity may be detrimental to the joints at risk of knee
osteoarthritis. Too low levels of activity may not stimulate the beneﬁcial
metabolic activity, while too high activity level may lead to detrimental
mechanical stress. Moderate activity level has thus been suggested as
beneﬁcial in preserving the knee joint by an enhanced metabolic
activity within the cartilage cells. The aim of this study was to inves-
tigate the association between physical activity level and knee struc-
tural damage, either as joint space narrowing (JSN) or cartilage loss, in
individuals with or at risk of knee osteoarthritis. We hypothesized that
individuals with low or high physical activity level would have a higher
degree of JSN than those with moderate activity level. Furthermore, we
hypothesized that individuals with low or high physical activity level
would have a higher degree of worsening of cartilage morphology than
people with moderate activity level.
Methods: Data from the Multicenter Osteoarthritis (MOST) Study were
used. We included study participants with physical activity data from
the 60-month visit, since this was the ﬁrst time physical activity was
objectively monitored, who had Kellgren and Lawrence (KL) grades 0-2.
Participants wore an accelerometer-enabled monitor, the StepWatch, to
record steps per day over 7 days. A valid day was deﬁned as >10 hours
of data, and we included those with at least 3 valid days of data. The
StepWatch data were not converted to be comparable to pedometer
data. Subjects were classiﬁed into tertiles based on their average
